BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Quercetin
,
rs2300478
,
DNMT1
,
cell-cell adhesion
,
Ischemia
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
methoxamine
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an e…
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure a…
The effect of high-fructose intake on the vasopressor response to angiotensin II and adrenergic agon…
Alterations in aortic wave reflection with vasodilation and vasoconstriction in anaesthetized dogs.
Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging…
Alpha-Blockers in Allergic Rhinitis (MAN 01)
Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ